Procedure for the monitoring of gabapentin with 2,4,6-trinitrobenzene sulfonic acid derivatization followed by HPLC with ultraviolet detection.
Juenke
JoEtta M
JM
ARUP Institute for Clinical and Experimental Pathology, ARUP Laboratories Inc, 500 Chipeta Way, Salt Lake City, UT 84108, USA. juenkejm@aruplab.com
Brown
Paul I
PI
McMillin
Gwendolyn A
GA
Urry
Francis M
FM
D000085:Acetates / Q000097:blood*; D000588:Amines; D000927:Anticonvulsants / Q000097:blood*; D002851:Chromatography, High Pressure Liquid; D003509:Cyclohexanecarboxylic Acids; D016903:Drug Monitoring / Q000379:methods*; D000077206:Gabapentin; D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D007202:Indicators and Reagents; D012015:Reference Standards; D013056:Spectrophotometry, Ultraviolet; D014302:Trinitrobenzenesulfonic Acid; D005680:gamma-Aminobutyric Acid
D000085:Acetates; D000588:Amines; D000927:Anticonvulsants; D003509:Cyclohexanecarboxylic Acids; D007202:Indicators and Reagents; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin; D014302:Trinitrobenzenesulfonic Acid